An improved synthesis of sunitinib malate via a solvent-free decarboxylation process

被引:18
作者
Meng, Ge [1 ]
Liu, Chunyan [1 ]
Qin, Shidong [1 ]
Dong, Mengshu [2 ]
Wei, Xiaomi [1 ]
Zheng, Meilin [1 ]
Qin, Liwen [1 ]
Wang, Huihui [1 ]
He, Xiaoshuang [1 ]
Zhang, Zhiguo [1 ]
机构
[1] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Software Engn, Xian 710049, Shaanxi, Peoples R China
关键词
Sunitinib; SU11248; Sutent; Synthesis; Optimization; Solvent-free; Standard design; TYROSINE KINASE; DERIVATIVES; INHIBITORS; DISCOVERY; VEGF;
D O I
10.1007/s11164-015-1939-z
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To search for an economical and convenient synthesis of sunitinib and its malate salt, optimization of a scalable synthetic route was explored by designing a standard experimental protocol on laboratory scale using commercially available materials including acetyl ethyl acetate, 4-fluoroaniline, and N (1),N (1)-diethylethane-1,2-diamine. The optimal conditions were established based on investigating the main reaction steps, including cyclization, hydrolysis, decarboxylation, formylation, and condensation, giving optimized yields for each step of 94.4, 97.6, 98.5, 97.1, 91.0, 86.3, 85.5, 88.2, 99.1, 97.3, and 58.7 %, respectively. The synthesis process of 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid as the important intermediate was significantly improved by using solvent-free decarboxylation instead of the traditional process in a high-boiling-point solvent. The subsequent formylation was conducted directly using the dichloromethane solution of the crude product from decarboxylation, leading to an almost quantitative combined yield of these two steps. The overall yields of sunitinib and its salt using the optimal synthesis process were 67.3 and 40.0 % based on acetyl ethyl acetate. The obtained data could be used as reference for future industrialization, especially for avoiding expensive solvents and reducing reaction time.
引用
收藏
页码:8941 / 8954
页数:14
相关论文
共 20 条
  • [1] THE SYNTHESIS OF KNORR PYRROLE BY INVERSE ADDITION
    COONEY, JV
    BEAL, EJ
    HAZLETT, RN
    [J]. ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 1983, 15 (04) : 292 - 295
  • [2] [董肖椿 DONG Xiaochun], 2008, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V18, P28
  • [3] Fang Z., 2010, HUAXUE SHIJI, V32, P82
  • [4] [方正 FANG Zheng], 2007, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V38, P822
  • [5] JOSHI KC, 1980, PHARMAZIE, V35, P677
  • [6] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997)
    Lipinski, CA
    Lombardo, F
    Dominy, BW
    Feeney, PJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 3 - 26
  • [7] [刘彪 LIU Biao], 2007, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V38, P539
  • [8] Lv K., 2009, J MED CHEM, V19, P116
  • [9] Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides
    Lv, Kai
    Wang, Li-Li
    Liu, Ming-Liang
    Zhou, Xin-Bo
    Fan, Shi-Yong
    Liu, Hong-Ying
    Zheng, Zhi-Bing
    Li, Song
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 3062 - 3065
  • [10] Early amidation approach to 3-[(4-amido)pyrrol-2-yl]-2-indolinones
    Manley, JM
    Kalman, MJ
    Conway, BG
    Ball, CC
    Havens, JL
    Vaidyanathan, R
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (16) : 6447 - 6450